Area of research
Physiology · Immunology
Research interest
Research focused on Asymmetric dimethylarginine and Arginine, with related work in CD40, Hazard ratio, Immune system. Notable publications include 'Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis', 'Homoarginine Levels Are Regulated by l -Arginine:Glycine Amidinotransferase and Affect Stroke Outcome', and 'Deficiency of the T cell regulator Casitas B-cell lymphoma-B aggravates atherosclerosis by inducing CD8+ T cell-mediated macrophage death'.
Ezh2 Shapes T Cell Plasticity to Drive Atherosclerosis
CD40-TRAF6 inhibition suppresses cardiovascular inflammation, oxidative stress and functional complications in a mouse model of arterial hypertension
Role of inflammatory signaling pathways involving the CD40–CD40L–TRAF cascade in diabetes and hypertension—insights from animal and human studies
Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis
Deficiency of the T cell regulator <i>Casitas B-cell lymphoma-B</i> aggravates atherosclerosis by inducing CD8+ T cell-mediated macrophage death
Low Homoarginine Levels in the Prognosis of Patients With Acute Chest Pain
Biosynthesis of homoarginine (hArg) and asymmetric dimethylarginine (ADMA) from acutely and chronically administered free l-arginine in humans
Reference intervals of plasma homoarginine from the German Gutenberg Health Study
ADMA, subclinical changes and atrial fibrillation in the general population
ADMA and arginine derivatives in relation to non-invasive vascular function in the general population
Homoarginine Levels Are Regulated by <scp>l</scp> -Arginine:Glycine Amidinotransferase and Affect Stroke Outcome